31 – 40 of 142
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Protocol for the T-REX-trial : Tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases - An open, multicentre, randomised non-inferiority phase 3 trial
Alkner, Sara LU ; De Boniface, Jana ; Lundstedt, Dan ; Mjaaland, Ingvil ; Ryden, Lisa LU
; Vikstrom, Johan
; Bendahl, Pär Ola
LU
; Holmberg, Erik
; Sackey, Helena
and Wieslander, Elinore
, et al.
(2023)
In BMJ Open
13(9).
- Contribution to journal › Article
-
Mark
Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer : data from the randomized SBII:2 trial
Lundgren, Christine LU ; Tutzauer, Julia LU
; Church, Sarah E.
; Stål, Olle
; Ekholm, Maria
LU
; Forsare, Carina
LU
; Nordenskjöld, Bo
; Fernö, Mårten
LU
; Bendahl, Pär Ola
LU
and Rydén, Lisa
LU
(2023)
In Breast Cancer Research
25(1).
- Contribution to journal › Article
-
Mark
Noninvasive Staging of Lymph Node Status in Breast Cancer Using Machine Learning : External Validation and Further Model Development
Hjärtström, Malin LU
; Dihge, Looket
LU
; Bendahl, Pär Ola
LU
; Skarping, Ida
LU
; Ellbrant, Julia
LU
; Ohlsson, Mattias
and Rydén, Lisa
LU
(2023)
In JMIR Cancer
9(1).
- Contribution to journal › Article
-
Mark
Matched analysis of circulating selenium with the breast cancer selenotranscriptome: a multicentre prospective study
Demircan, Kamil ; Bengtsson, Ylva LU
; Samson Chillon, Thilo
; Vallon-Christersson, Johan
LU
; Sun, Qian
; Larsson, Christer
LU
; Malmberg, Martin
; Saal, Lao
LU
; Ryden, Lisa
LU
and Borg, Åke
LU
, et al.
(2023)
In Journal of Translational Medicine
- Contribution to journal › Article
-
Mark
Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy
Nordenskjöld, Anna ; Fohlin, Helena ; Rosell, Johan ; Bengtsson, Nils Olof ; Fornander, Tommy ; Hatschek, Thomas ; Lindman, Henrik ; Malmström, Per LU ; Rydén, Lisa LU
and Wallgren, Arne
, et al.
(2023)
In Breast
71.
p.63-68
- Contribution to journal › Article
-
Mark
Risk-adjusted benchmarking of long-term overall survival in patients with HER2-positive early-stage Breast cancer : A Swedish retrospective cohort study
Thurell, Jacob ; Manouchehri, Narges ; Fredriksson, Irma ; Wilking, Ulla ; Bergh, Jonas ; Ryden, Lisa LU
; Koppert, Linetta B.
; Karsten, Maria M.
; Kiani, Narsis A.
and Hedayati, Elham
(2023)
In Breast
70.
p.18-24
- Contribution to journal › Article
-
Mark
Risk factors for seroma formation after axillary lymph node dissection with special focus on the impact of early shoulder exercise
- Contribution to journal › Article
-
Mark
Gene expression in metastatic breast cancer—patterns in primary tumors and metastatic tissue with prognostic potential
Tutzauer, Julia LU
; Larsson, Anna Maria
LU
; Aaltonen, Kristina
LU
; Bergenfelz, Caroline
LU
; Bendahl, Pär Ola
LU
and Rydén, Lisa
LU
(2023)
In Frontiers in Molecular Biosciences
10.
- Contribution to journal › Article
- 2022
-
Mark
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
Staaf, Johan LU
; Häkkinen, Jari
LU
; Hegardt, Cecilia
LU
; Saal, Lao H
LU
; Kimbung, Siker
LU
; Hedenfalk, Ingrid
LU
; Lien, Tonje
; Sørlie, Therese
; Naume, Bjørn
and Russnes, Hege
, et al.
(2022)
In npj Breast Cancer
8.
p.1-17
- Contribution to journal › Article
-
Mark
How Reliable Are Gene Expression-Based and Immunohistochemical Biomarkers Assessed on a Core-Needle Biopsy? A Study of Paired Core-Needle Biopsies and Surgical Specimens in Early Breast Cancer
Saghir, Hani LU ; Veerla, Srinivas LU
; Malmberg, Martin
; Rydén, Lisa
LU
; Ehinger, Anna
LU
; Saal, Lao H.
LU
; Vallon-Christersson, Johan
LU
; Borg, Åke
LU
; Hegardt, Cecilia
LU
and Larsson, Christer
LU
, et al.
(2022)
In Cancers
14(16).
p.1-16
- Contribution to journal › Article